The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cellsin vitro-Reference-Cited by-同舟云学术

The phosphatidylinositol-3 kinase I inhibitor BKM120 induces cell death in B-chronic lymphocytic leukemia cellsin vitro

Published:2013-01-15 Issue:1 Volume:133 Page:247-252
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Amrein Lilian¹,Shawi May¹,Grenier Jeremy¹,Aloyz Raquel¹,Panasci Lawrence¹

Affiliation:

1. Department of Oncology; Faculty of Medicine; McGill University; Lady Davis Institute-Segal Cancer Center from the Jewish General Hospital; Montreal; Quebec; Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference21 articles.

1. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells;Klein;J Exp Med,2001

2. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1;Burger;Blood,2000

3. Update on therapy of chronic lymphocytic leukemia;Gribben;J Clin Oncol,2011

4. The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo;Ponader;Blood,2012

5. The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia;Rooij;Blood,2012

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities;Cancers;2023-11-05

2. PI3K inhibitors in chronic lymphocytic leukemia: where do we go from here?;Haematologica;2022-07-28

3. The Superior Cytotoxicity of Dual Targeting of BCR/ABL and PI3K in K562 Cells: Proposing a Novel Therapeutic Potential for the Treatment of CML;Indian Journal of Hematology and Blood Transfusion;2021-04-01

4. The influence of PI3K inhibition on the radiotherapy response of head and neck cancer cells;Scientific Reports;2020-10-01

5. PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma;Current Treatment Options in Oncology;2020-04-30